Association Between Clinical Manifestations and Prognosis in Patients with COVID-19

Tao Yu(Nanfang Hospital), Xuwen Xu(Nanfang Hospital), Sichun Yin(Dongguan People’s Hospital), Zhidan Zheng(Dongguan People’s Hospital), Yuanyuan Liu(Dongguan People’s Hospital), Xuejuan Cai(Dongguan People’s Hospital), Jie Peng(Guiyang Medical University), Shaohang Cai(Key Laboratory of Guangdong Province)

Clinical Therapeutics

April 26, 2020

10.1016/j.clinthera.2020.04.009

Cited by 84

Related Papers

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging

|European Radiology|2019|219

Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling

|Cancer Research|2021|127

ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China

|medRxiv|2020|112

<i>Retracted:</i><scp>HB</scp>x‐mediated decrease of <scp>AIM</scp>2 contributes to hepatocellular carcinoma metastasis

|Molecular Oncology|2017|92

Association between obesity and clinical prognosis in patients infected with SARS-CoV-2

|Infectious Diseases of Poverty|2020|84